Home » Topics » Regulatory

Regulatory
RSS

ODAC recommends approval of another new indication for Taxol

Sep. 20, 1999

FDA approves Rapamune for rejection prevention in renal transplantation

Sep. 17, 1999

Novo Nordisk's liquid growth hormone approved in the E.U.

Sep. 17, 1999

Colazide approved for ulcerative colitis maintenance in Europe

Sep. 17, 1999

NovoRapid approved in E.U. for treatment of diabetes

Sep. 10, 1999

Fujisawa seeks approval for tacrolimus ointment in the U.S.

Sep. 10, 1999

FDA approves new indications for Zerit and Videx

Sep. 9, 1999

New ulcer drug approved for the first time in Japan

Sep. 1, 1999

Eisai's proton pump inhibitor approved in E.U. for GERD maintenance

Sep. 1, 1999

Celecoxib NDA receives priority review designation for FAP

Aug. 31, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
In 2025, science’s biggest story was political
BioWorld
In 2025, science saw its breakthroughs, which BioWorld will be covering as part of our end-of-the-year wrap-up. But the biggest science story of 2025 is not about...
FDA says yes to Cytokinetics’ aficamten, now Myqorzo, in oHCM
BioWorld
Cytokinetics Inc. scored U.S. FDA marketing clearance Dec. 19 for Myqorzo (aficamten) 5-mg, 10-mg, 15-mg, and 20-mg tablets to improve functional capacity and...
Conjugating ferrocene to GPX4 inhibitors to promote ferroptosis
BioWorld Science
Small molecules that induce iron-dependent oxidative cell death known as ferroptosis can be effective against tumors that are resistant to other therapies....